Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...

Just a year ago, Chinese manufacturers, fearing a new trade war, rushed to push out exports following the election victory of ...

Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent ...

Various agreements with the Trump administration could have long-term ramifications for Medicaid access and global pricing strategy.

Johnson & Johnson JNJ and Pfizer PFE are both healthcare leaders with large drug portfolios and diversified revenue streams, ...

Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...

Trouble for Simon Harris is that GDP figures don’t tend to cheer you up if you are juggling a long commute, childcare costs ...

Eli Lilly, Johnson & Johnson and Sanofi stay in focus as Big Pharma shows signs of recovery amid innovation, M&A and easing ...

Businesses, including ones in the chemical industry, are awaiting a US Supreme Court ruling on the legality of import tariffs ...

BRAINTREE, MASS. (WHDH) - With Thanksgiving in the rear view mirror, the holiday shopping season kicked off on Black Friday with shoppers heading out early in hopes of scoring deals. It might be the ...

Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong leadership positions in distinct therapeutic areas. NVO is widely recognized ...

Christmas decoration items are seen at a supermarket in Houston, Texas, on November 18, 2025. Tariffs imposed on imports by US President Donald Trump increased the prices of many Christmas decorations ...